4R8-27677-92470
4 vaccinations
3 coded responses
37 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Health check-in — day 0, dose 1Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
-
2021-02-18
Dose 2 — Pfizer-BioNTech
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
-
2021-03-25
Survey response — day 35, dose 2MedDRA: Diarrhoea, Impaired work ability, Pyrexia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Mild fever and terrible diarrhea for one day only. Miss 1/2 day of work.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-05-20
- 2021-08-19
-
2021-08-20
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-01
- 2021-11-19
- 2022-02-18
-
2022-04-27
Dose 4 — Pfizer-BioNTech
- 2022-05-16
- 2022-05-18
- 2022-05-25
-
2022-06-01
Survey response — day 35, dose 4MedDRA: Fatigue, Rhinorrhoea — Feeling: GoodFree text: Fatigue and runny nose (probably due to high pollen)MedDRA releases: 2024-11 · check-in free text available
- 2022-06-08
- 2022-07-31
- 2022-10-26
-
2023-04-27
Survey response — 12 months, dose 4MedDRA: Thyroid disorder, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-27
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2021-08-20 | Pfizer-BioNTech | No |
| 4 | 2022-04-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-27 | Unsuccessful |
Free text
Release 6 — day 35, dose 2
Symptoms: Mild fever and terrible diarrhea for one day only. Miss 1/2 day of work.
Release 11 — day 35, dose 4
Symptoms: Fatigue and runny nose (probably due to high pollen)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Impaired work ability | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Thyroid disorder | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release